(Q38478259)

3 September 2017

title

Retinal and extraocular cytomegalovirus end-organ disease in HIV-infected patients in Europe: a EuroSIDA study, 1994-2001. (English)

1 reference

3 September 2017

0 references

7

C Katlama

1 reference

3 September 2017

10

O Kirk

1 reference

3 September 2017

9

P Reiss

1 reference

3 September 2017

6

A Mocroft

1 reference

3 September 2017

I Yust

1

1 reference

3 September 2017

Z Fox

2

1 reference

3 September 2017

M Burke

3

1 reference

3 September 2017

A Johnson

4

1 reference

3 September 2017

D Turner

5

1 reference

3 September 2017

B Ledergerber

8

1 reference

3 September 2017

EuroSIDA

11

1 reference

3 September 2017

language of work or name

1 reference

30 June 2004

1 reference

European Journal of Clinical Microbiology & Infectious Diseases

3 September 2017

published in

1 reference

3 September 2017

volume

23

1 reference

3 September 2017

issue

7

1 reference

3 September 2017

page(s)

550-559

1 reference

https://scigraph.springernature.com/pub.10.1007/s10096-004-1160-2

3 September 2017

exact match

0 references

cites work

Discontinuation of anticytomegalovirus therapy in patients with HIV infection and cytomegalovirus retinitis

1 reference

12 December 2020

Increasing survival in AIDS patients with cytomegalovirus retinitis treated with combination antiretroviral therapy including HIV protease inhibitors

1 reference

12 December 2020

Opportunistic infections of the central nervous system during HIV-1 infection (emphasis on cytomegalovirus disease).

1 reference

12 December 2020

Cytomegalovirus pneumonia.

1 reference

12 December 2020

Decrease of cytomegalovirus replication in human immunodeficiency virus infected-patients after treatment with highly active antiretroviral therapy

1 reference

12 December 2020

Overview of cytomegalovirus infections in HIV-infected patients: current therapies and future strategies

1 reference

12 December 2020

AIDS and ophthalmology: a period of transition

1 reference

12 December 2020

Changes in the natural history of cytomegalovirus retinitis following the introduction of highly active antiretroviral therapy

1 reference

12 December 2020

Guidelines for the treatment of cytomegalovirus diseases in patients with AIDS in the era of potent antiretroviral therapy: recommendations of an international panel. International AIDS Society-USA.

1 reference

12 December 2020

Clearance of cytomegalovirus viremia after initiation of highly active antiretroviral therapy

1 reference

12 December 2020

Hepatic Histopathology in the Acquired Immunodeficiency Syndrome

1 reference

12 December 2020

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

1 reference

12 December 2020

Outcome of AIDS-associated cytomegalovirus colitis in the era of potent antiretroviral therapy.

1 reference

12 December 2020

Pulmonary cytomegalovirus infection in immunocompromised patients

1 reference

12 December 2020

Natural history and outcome of new AIDS-related cytomegalovirus retinitis diagnosed in the era of highly active antiretroviral therapy

1 reference

12 December 2020

Polyradiculopathy associated with ganciclovir-resistant cytomegalovirus in an AIDS patient: phenotypic and genotypic characterization of sequential virus isolates

1 reference

12 December 2020

Cytomegalovirus retinitis in patients with AIDS in Europe

1 reference

12 December 2020

Cytomegalovirus encephalitis in acquired immunodeficiency syndrome (AIDS).

1 reference

12 December 2020

Discontinuation of secondary prophylaxis for opportunistic infections in HIV-infected patients receiving highly active antiretroviral therapy

1 reference

12 December 2020

Effect of highly active antiretroviral therapy on cytomegalovirus antigenaemia in AIDS patients

1 reference

12 December 2020

Cytomegalovirus (CMV)-specific CD4+ T lymphocyte immune function in long-term survivors of AIDS-related CMV end-organ disease who are receiving potent antiretroviral therapy

1 reference

12 December 2020

Regional differences in use of antiretroviral agents and primary prophylaxis in 3122 European HIV-infected patients. EuroSIDA Study Group

1 reference

12 December 2020

Cytomegalovirus colitis in AIDS: presentation in 44 patients and a review of the literature

1 reference

12 December 2020

Incidence and natural history of cytomegalovirus disease in patients with advanced human immunodeficiency virus disease treated with zidovudine. The Zidovudine Epidemiology Study Group

1 reference

12 December 2020

Clinical manifestations and survival trends during the first 12 years of the AIDS epidemic in Mexico

1 reference

12 December 2020

Clinico-pathological study of cytomegalovirus (CMV) in AIDS autopsies: under-recognition of CMV pneumonitis and CMV adrenalitis

1 reference

12 December 2020

Cytomegalovirus esophagitis in AIDS: a prospective evaluation of clinical response to ganciclovir therapy, relapse rate, and long-term outcome

1 reference

12 December 2020

AIDS defining diseases in the UK: the impact of PCP prophylaxis and twelve years of change

1 reference

12 December 2020

Diagnosis and treatment of esophageal diseases associated with HIV infection. Practice Parameters Committee of the American College of Gastroenterology

1 reference

12 December 2020

Autopsy findings in the acquired immunodeficiency syndrome (AIDS). A report of 395 cases from the south of France

1 reference

12 December 2020

Impact of highly active antiretroviral therapy on onset of Mycobacterium avium complex infection and cytomegalovirus disease in patients with AIDS

1 reference

12 December 2020

Incidence of immune recovery vitritis in cytomegalovirus retinitis patients following institution of successful highly active antiretroviral therapy

1 reference

12 December 2020

Autopsy pathology in the acquired immune deficiency syndrome

1 reference

12 December 2020

Safe Interruption of Maintenance Therapy against Previous Infection with Four Common HIV-Associated Opportunistic Pathogens during Potent Antiretroviral Therapy

1 reference

12 December 2020

Human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy maintain activated CD8+ T cell subsets as a strong adaptive immune response to cytomegalovirus.

1 reference

12 December 2020

The incidence of cytomegalovirus (CMV) antigenemia and CMV disease is reduced by highly active antiretroviral therapy

1 reference

12 December 2020

Cytomegalovirus infection in patients with HIV infection

1 reference

12 December 2020

Clinical features and outcomes of HIV-related cytomegalovirus pneumonia

1 reference

12 December 2020

Clinical manifestations of AIDS in the era of pneumocystis prophylaxis. Multicenter AIDS Cohort Study

1 reference

12 December 2020

Clinical impact of cytomegalovirus infections of the nervous system in patients with AIDS.

1 reference

12 December 2020

10.1007/S10096-004-1160-2

Identifiers

DOI

1 reference

Dimensions Publication ID

3 September 2017

1028176234

0 references

1 reference